Associate Sponsors

Home / India News / Bafna Pharmaceuticals announces upgradation of credit ratings

Bafna Pharmaceuticals announces upgradation of credit ratings

Image
Capital Market
Last Updated : Nov 19 2014 | 7:04 PM IST
LinkedIN IconFacebook Icon

From CRISIL

Bafna Pharmaceuticals announced that CRISIL has upgraded the rating as CRISIL BB-/stable (Upgraded from CRISIL D) for Long Term rating & CRISIL A4+ (Upgraded from CRISIL D) for Short term Rating in respect of Total bank facilities.

Powered by Capital Market - Live News

Connect with us on WhatsApp

More From This Section

Outcome of board meeting of Simplex Projects

Board of Paragon Finance appoints director

Saurashtra Cement appoints nominee director

Sahara One Media & Entertainment terminates MoU with Triologic Digital Media

First Published: Nov 19 2014 | 3:02 PM IST

Explore News

Next Story